Intensive Chemotherapy With Idarubicin, Cytosine Arabinoside, and Granulocyte Colony-Stimulating Factor (G-Csf) in Patients With Secondary and Therapy-Related Acute Myelogenous Leukemia
Leukemia - United Kingdom
doi 10.1038/sj.leu.2400536
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1997
Authors
Publisher
Springer Science and Business Media LLC